Search results
Results From The WOW.Com Content Network
It was developed by heart surgeon Dr. Michael DeBakey [4] for blood transfusions [5] while he was a medical student in 1932 and later used by him for cardiopulmonary bypass [6] systems. A specialized nonocclusive roller pump (US Patent 5222880) [7] using soft flat tubing was developed in 1992 for cardiopulmonary bypass systems.
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois.It had approximately 19,000 employees. [1] Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, [2] manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication ...
Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest.
White House on Thursday denied it is drafting an executive order to cut workers across federal health agencies. According to the Wall Street Journal, under the order, which could come as soon as ...
Affect infusion and affect control: The interactive role of conscious and unconscious processing strategies in mood management. In: Y. Rossetti & A. Revonsuo (Eds.). Beyond dissociation: Interaction between dissociated implicit and explicit processing.
Dr. Michael Fingerhood, an associate professor of medicine at Johns Hopkins University in Baltimore, is the medical director of a primary care practice that treats 450 patients with buprenorphine. In 2009, the practice found that some 40 percent of its patients dropped their Suboxone regimen after a year.
Michael A. Caligiuri is an American physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. [ 3 ]